Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Intangibles (2021 - 2025)

AC Immune (ACIU) has disclosed Intangibles for 5 consecutive years, with $63.1 million as the latest value for Q4 2025.

  • Quarterly Intangibles rose 9.61% to $63.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $63.1 million through Dec 2025, up 9.61% year-over-year, with the annual reading at $63.1 million for FY2025, 9.61% up from the prior year.
  • Intangibles for Q4 2025 was $63.1 million at AC Immune, up from $57.6 million in the prior quarter.
  • The five-year high for Intangibles was $63.1 million in Q4 2025, with the low at $52.3 million in Q4 2022.
  • Average Intangibles over 5 years is $56.9 million, with a median of $56.8 million recorded in 2023.
  • The sharpest move saw Intangibles decreased 4.29% in 2022, then increased 9.61% in 2025.
  • Over 5 years, Intangibles stood at $54.7 million in 2021, then decreased by 4.29% to $52.3 million in 2022, then increased by 8.61% to $56.8 million in 2023, then grew by 1.26% to $57.6 million in 2024, then rose by 9.61% to $63.1 million in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $63.1 million, $57.6 million, and $56.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.